onCOGITE

Name

onCOGITE

Legal name

Association onCOGITE

Website

https://oncogite.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Cognitive Remediation Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Home Health Care Services (62161)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industry

Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Cognitive remediation services
• Cancer survivorship care
• Chemobrain treatment
• Neuropsychology workshops
• Online cognitive training

Headquarters

HQ city

Bordeaux

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Patient Membership Dues: Patients pay a nominal annual membership fee of 20 euros upon account creation. The 20 cognitive remediation sessions are provided free of charge to patients, funded by financial partners and donors. The membership grants access to workshops with neuropsychologists and the onCOGITiel web application for the duration of the year.
2. Donations: onCOGITE is a recognized association of general interest (intérêt général) eligible to receive tax-deductible donations. Donation options of 20, 50, and 100 euros are offered, with donors receiving a tax receipt.
3. Professional Membership: Healthcare professionals (neuropsychologists) pay an enhanced membership contribution to participate as workshop facilitators in the onCOGITE remediation parcours.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

onCOGITE delivers structured, neuroscience-based cognitive remediation programs for cancer patients in France experiencing post-treatment cognitive difficulties (chemobrain/brain fog). The core offering combines weekly 90-minute live group workshops led by neuropsychologists (delivered via Zoom nationwide) with the proprietary onCOGITiel web application for asynchronous at-home brain training. The standard parcours covers memory, attention, language, and executive functions across 20 sessions per year, with a specialized track (onCOGIT'aja) for adolescents and young adults aged 15-30.

Product overview

onCOGITE is a non-profit association offering cognitive remediation programs for cancer survivors experiencing post-treatment cognitive difficulties ('chemobrain' or 'cognitive fog'). The core offering consists of two main programs: onCOGITE for adults (featuring weekly 1.5-hour group workshops via video conference with neuropsychologists) and onCOGIT'aja for adolescents and young adults aged 15-30 (featuring weekly 1-hour workshops). Both programs include up to 20 supervised sessions plus access to onCOGITiel, a companion web application for self-guided brain training exercises. An introductory session called ONCO'MMENCE is offered before starting the main program. The platform also provides resources for caregivers through dedicated spaces.

Differentiator

Problem solved

Functional benefit

Brands

• onCOGIT'aja: Specialized cognitive remediation program for Adolescents and Young Adults (AJA) aged 15-30 who have or have had cancer and experience cognitive difficulties. Launched in December 2024, featuring weekly one-hour workshops via video conference designed specifically for young people, facilitated by qualified neuropsychology therapists.
• onCOGITiel
• Oncobrain

Products and services

• onCOGITE (adult cognitive remediation workshops) Core cognitive remediation programme for adults in France who have or have had cancer and experience post-treatment cognitive difficulties (chemobrain/brain fog). Comprises up to 20 weekly 90-minute group workshops led by neuropsychologists covering memory, attention, language, and executive functions, delivered via video-conference across France.
• onCOGIT'aja (adolescent and young adult programme) Specialized cognitive remediation programme for adolescents and young adults aged 15-30 who have or have had cancer and experience cognitive difficulties. Delivered as weekly 1-hour group workshops via video conference in groups of 8-10 participants, led by trained neuropsychologists, with exercises tailored to the AJA segment including learning capacities and identity-development considerations.
• onCOGITiel (web application for autonomous brain training) Web application accessible to onCOGITE members during their annual membership, providing the same style of cognitive exercises as the workshops with progressive difficulty levels, enabling participants to continue brain training independently between and after supervised sessions.
• ONCO'MMENCE (introductory onboarding session) Optional 1.5-hour introductory video-conference session animated by a neuropsychologist, recommended before starting the cognitive remediation programme. Explains cognitive difficulties and how the onCOGITE programme works so that new participants begin sessions well-prepared.

Quantifiable outcome

• Cognitive improvement (memory, attention, concentration) reported by patients after completing 15-20 sessions
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

37 partnerships are on record, tiered core and minor.

• Ligue Contre le CancercoreStrategic or Co-development PartnerThe Ligue Contre le Cancer is a major French cancer patient association and one of the key referral partners for onCOGITE. It promotes the onCOGITE cognitive remediation programme to its network of patients across France and has published articles about the service.
• Patients en RéseauminorStrategic or Co-development PartnerPatients en Réseau is a French patient network organization that collaborates with onCOGITE to reach cancer patients experiencing cognitive difficulties.
• Institut de Cancérologie de l'Ouest (ICO)coreStrategic or Co-development PartnerICO is a major cancer treatment center in France that partners with onCOGITE, including hosting awareness events such as October Rose conferences and providing patient referrals.
• Institut de Cancérologie de LorrainecoreStrategic or Co-development PartnerICL is a cancer treatment center in Lorraine, France that partners with onCOGITE for cognitive remediation services for their patients.
• Centre Eugène MarquiscoreStrategic or Co-development PartnerA cancer treatment center in Rennes, France partnering with onCOGITE to provide cognitive remediation services to their patient population.
• CHU de Brest (La Cavale Blanche)coreStrategic or Co-development PartnerThe CHU de Brest, a major university hospital in Brittany, is a partner of onCOGITE. The association maintains a stand at the hospital for patient outreach and awareness.
• Centre Léonard de VincicoreStrategic or Co-development PartnerCentre Léonard de Vinci is a private hospital in Hauts-de-France partnering with onCOGITE for cognitive remediation services.
• Institut du Sein de Grand Toulouse (ISGT)coreStrategic or Co-development PartnerA breast cancer treatment center in Toulouse partnering with onCOGITE.
• Institut du Sein de Charentes MaritimecoreStrategic or Co-development PartnerA breast cancer treatment center in Charentes-Maritime partnering with onCOGITE.
• Institut de Cancérologie Avignon-Provence (ISC)coreStrategic or Co-development PartnerA cancer treatment center in Avignon, Provence, partnering with onCOGITE.
• Institut du Cancer Avignon-ProvencecoreStrategic or Co-development PartnerA cancer treatment center in Avignon, Provence, partnering with onCOGITE.
• IUCT-Oncopole Toulouse (IRCB)coreStrategic or Co-development PartnerThe IUCT-Oncopole in Toulouse, a major French cancer center, partners with onCOGITE for cognitive remediation of their patients.
• Hôpital Privé Médipôle de SavoiecoreStrategic or Co-development PartnerA private hospital in Savoie, France, partnering with onCOGITE.
• Confluent (Vivalto Santé)coreStrategic or Co-development PartnerThe Confluent private hospital group (Vivalto Santé) partners with onCOGITE.
• ONCOGARD (ElsAN)coreStrategic or Co-development PartnerONCOGARD, part of the ElsAN private hospital network, partners with onCOGITE.
• CHD VendéecoreStrategic or Co-development PartnerCentre Hospitalier Départemental de Vendée partners with onCOGITE.
• CHU PoitierscoreStrategic or Co-development PartnerCHU Poitiers university hospital partners with onCOGITE for patient cognitive remediation services.
• CH Annecy GenevoiscoreStrategic or Co-development PartnerCentre Hospitalier Annecy Genevois partners with onCOGITE.
• Centre Hospitalier TroyescoreStrategic or Co-development PartnerCentre Hospitalier de Troyes partners with onCOGITE.
• Hôpital Saint-Joseph (FHSJ)coreStrategic or Co-development PartnerHôpital Saint-Joseph in Marseille partners with onCOGITE.
• Institut Godinot ReimscoreStrategic or Co-development PartnerInstitut Godinot in Reims, a dedicated cancer center, partners with onCOGITE.
• GHM GrenoblecoreStrategic or Co-development PartnerGHM (Groupe Hospitalier Mutualiste) in Grenoble partners with onCOGITE.
• Groupement Hospitalier Est — HCL LyoncoreStrategic or Co-development PartnerGroupement Hospitalier Est des Hôpitaux Civils de Lyon partners with onCOGITE.
• IRFC (Institut de Recherche en Cancérologie de Montpellier)coreStrategic or Co-development PartnerIRFC Montpellier partners with onCOGITE.
• AOMR (Association Oncologie Médicale du Limousin)coreStrategic or Co-development PartnerAOMR in Limoges, an oncology medical association, partners with onCOGITE.
• Institut Andrée DutreixcoreStrategic or Co-development PartnerInstitut Andrée Dutreix, a cancer treatment center, partners with onCOGITE.
• Maison Autour de la VieminorStrategic or Co-development PartnerMaison Autour de la Vie is an oncology support association in Oise that partners with onCOGITE.
• L'Oasis des DômesminorStrategic or Co-development PartnerL'Oasis des Dômes is an oncology support association that partners with onCOGITE.
• Cami Sport & CancerminorStrategic or Co-development PartnerCami Sport & Cancer is a French organization promoting physical activity for cancer patients, and is listed as a trust partner of onCOGITE.
• Oligocyte BretagneminorStrategic or Co-development PartnerOligocyte Bretagne is a neurological/cognitive care organization in Brittany partnering with onCOGITE.
• La Gaillarde (CHU de Bordeaux)minorStrategic or Co-development PartnerLa Gaillarde, a healthcare facility in Brive-la-Gaillarde, is listed as a trust partner.
• Le Mis MontpellierminorStrategic or Co-development PartnerLe Mis Montpellier is a healthcare facility listed as a trust partner of onCOGITE.
• Soeurs d'EncreminorStrategic or Co-development PartnerSoeurs d'Encre is a partner organization of onCOGITE.
• RKS (Réseau des Kinésithérapeutes du Sein)minorStrategic or Co-development PartnerThe RKS breast health physiotherapy network partners with onCOGITE.
• URSSAFminorOthersURSSAF, the French social security contributions collector, is listed as a partner of onCOGITE in the context of the association's regulatory compliance.
• Go-AJAcoreStrategic or Co-development PartnerGo-AJA is a partner organization dedicated to adolescents and young adults with cancer, collaborating with onCOGITE for the onCOGIT'aja programme.
• Au Coeur des AJAcoreStrategic or Co-development PartnerAu Coeur des AJA is a support organization for adolescents and young adults with cancer, partnering with onCOGITE for the onCOGIT'aja programme.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Constant Therapy: Constant Therapy is a digital therapy platform providing clinician-prescribed cognitive and speech exercises for patients recovering from stroke, TBI and other neurological conditions. It overlaps with onCOGITE in delivering structured cognitive rehabilitation through a digital interface with exercise progression, though it is anchored in neurological recovery rather than oncology-specific chemobrain.
• Akili Interactive (Virtual Therapeutics): Akili, now operating as Virtual Therapeutics, develops prescription digital therapeutics targeting cognition (notably ADHD and multiple sclerosis) and has explored oncology-related cognitive applications. It is comparable to onCOGITE in delivering digital, clinically framed cognitive interventions, though it operates a software-first, FDA-cleared model rather than live facilitated workshops.

Broad incumbents

• Posit Science (BrainHQ): Posit Science's BrainHQ is an established digital brain-training platform with clinically validated exercises targeting memory, attention and executive function. It is comparable to onCOGITE's onCOGITiel web application in offering structured cognitive exercises, but serves a broad consumer and clinical audience rather than a cancer-specific patient population.
• Lumos Labs (Lumosity): Lumosity is a large consumer-facing cognitive training platform offering exercises across memory, attention and flexibility. It is comparable to onCOGITE's onCOGITiel web app as a structured brain-training product, but operates in a consumer/B2C model without the clinical, facilitator-led cancer focus that differentiates onCOGITE.
• Cambridge Cognition: Cambridge Cognition supplies cloud-based cognitive assessment technology for clinical trials and healthcare providers, including studies in oncology and neurodegenerative disease. It overlaps with onCOGITE in addressing cognitive dysfunction through digital tools, but operates as a broad incumbent across CNS trials rather than a niche oncology remediation programme.

Direct peers

• Cogstate: Cogstate provides digital cognitive assessment tools widely used in oncology clinical trials, including measurement of chemotherapy-related cognitive decline. It is the closest commercial analog to onCOGITE in serving cognitive care needs of cancer populations, although it focuses on testing and trial endpoints rather than live remediation workshops.

Regional players

• HAPPYneuron (Scientific Brain Training): HAPPYneuron is a French-developed cognitive training platform used by clinicians and healthcare professionals in France. It is the most relevant French-market peer to onCOGITE on the digital cognitive training dimension, although it is not oncology-specific and serves a wider clinical population.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/oncogite
• Xx.com/oncogite
• LinkedInlinkedin.com/company/oncogite
• Pinterestpinterest.com/oncogite

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about onCOGITE